D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
Armstrong World Industries
AWI
$7.05B
| $1.24M | ﹤0.01% |
+12,800
| New | +$1.14M |
|
2502
CALL
Best Buy
BBY
$18.6B
| $1.24M | ﹤0.01% |
17,800
+12,800
| +256% | +$893K |
|
2503
Albany International
AIN
$2.16B
| $1.24M | ﹤0.01% |
14,939
-12,494
| -46% | -$935K |
|
2504
Agree Realty
ADC
$9.66B
| $1.24M | ﹤0.01% |
19,315
-10,401
| -35% | -$695K |
|
2505
Mizuho Financial
MFG
$129B
| $1.23M | ﹤0.01% |
428,380
+162,606
| +61% | +$482K |
|
|
BRSL
2506
PUT
Brightstar Lottery PLC
BRSL
$1.93B
| $1.23M | ﹤0.01% |
94,800
+14,800
| +19% | +$201K |
|
|
NVO
2507
Novo Nordisk
NVO
$220B
| $1.23M | ﹤0.01% |
48,178
-68,958
| -59% | -$1.7M |
|
2508
PUT
Strategic Education
STRA
$1.78B
| $1.23M | ﹤0.01% |
+6,900
| New | +$1.13M |
|
|
ZNGA
2509
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.23M | ﹤0.01% |
+200,000
| New | +$1.18M |
|
2510
Community Bank
CBU
$3.5B
| $1.23M | ﹤0.01% |
18,604
-2,197
| -11% | -$141K |
|
2511
The RMR Group
RMR
$348M
| $1.22M | ﹤0.01% |
26,006
+21,138
| +434% | +$1.14M |
|
2512
Core Laboratories
CLB
$518M
| $1.22M | ﹤0.01% |
23,342
+10,718
| +85% | +$629K |
|
|
ARNA
2513
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.22M | ﹤0.01% |
+20,788
| New | +$1.07M |
|
2514
PUT
Darden Restaurants
DRI
$23.4B
| $1.22M | ﹤0.01% |
10,000
| – | – |
|
2515
Customers Bancorp
CUBI
$2.66B
| $1.21M | ﹤0.01% |
57,765
-77,353
| -57% | -$1.61M |
|
|
WRK
2516
CALL
DELISTED
WestRock Company
WRK
| $1.21M | ﹤0.01% |
33,200
-6,800
| -17% | -$250K |
|
2517
CALL
Xerox
XRX
$357M
| $1.21M | ﹤0.01% |
34,100
| – | – |
|
2518
CALL
Cencora
COR
$60.5B
| $1.2M | ﹤0.01% |
14,100
| – | – |
|
2519
CALL
Invesco
IVZ
$13.3B
| $1.2M | ﹤0.01% |
+58,700
| New | +$1.22M |
|
2520
SLR Investment Corp
SLRC
$705M
| $1.2M | ﹤0.01% |
58,501
-3,144
| -5% | -$66.2K |
|
|
SEMG
2521
PUT
DELISTED
SEMGROUP CORPORATION
SEMG
| $1.2M | ﹤0.01% |
+100,000
| New | +$1.33M |
|
|
LION
2522
DELISTED
Fidelity Southern Corporation
LION
| $1.2M | ﹤0.01% |
38,676
-17,464
| -31% | -$509K |
|
2523
PNC Financial Services
PNC
$99.6B
| $1.2M | ﹤0.01% |
8,721
+941
| +12% | +$124K |
|
|
ZEN
2524
CALL
DELISTED
ZENDESK INC
ZEN
| $1.19M | ﹤0.01% |
+13,400
| New | +$1.15M |
|
|
PNNT
2525
Pennant Park Investment Corp
PNNT
$219M
| $1.19M | ﹤0.01% |
187,968
+8,747
| +5% | +$58.9K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.